The Global Controlled Release Drug Delivery Market size is
The coacervation provides various benefits including improved effectiveness, fewer side effects, convenience, and guaranteed linear medication...
Stay updated with breaking news from Intec Pharma Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The coacervation provides various benefits including improved effectiveness, fewer side effects, convenience, and guaranteed linear medication...
/PRNewswire/ -- According to Coherent Market Insights, the global fibromyalgia treatment market is estimated to be valued at US$ 3,142.4 million in 2022 and is...
/PRNewswire/ -- According to Coherent Market Insights, the global fibromyalgia treatment market is estimated to be valued at US$ 3,142.4 million in 2022 and is...
Intec Closes Merger with Decoy Biosystems USA - English Changes Corporate Name to Indaptus Therapeutics to Reflect Clinical Focus News provided by Share this article Share this article NEW YORK, Aug. 3, 2021 /PRNewswire/ -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company," and formerly, Intec Parent, Inc.) today announced the closing of its previously announced merger with Decoy Biosystems, Inc. ("Decoy") and the completion of a $30 million private placement in accordance with the merger agreement. In addition, the Company announced a corporate name change to Indaptus T...
7/30/2021 4:48:17 PM GMT Midway through trading Friday, the Dow traded down 0.25% to 34,996.01 while the NASDAQ fell 0.62% to 14,686.02. The S&P also fell, dropping 0.45% to 4,399.32. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 34,751,040 cases with around 612,120 deaths. India confirmed a total of at least 31,572,340 cases and 423,210 deaths, while Brazil reported over 19,839,360 COVID-19 cases with 554,490 deaths. In total, there were at least 196,684,500 cases of COVID-19 worldwide with more than 4,199,940 deaths, according to data com...